[SCHEDULE 13G/A] HORTON D R INC /DE/ Amended Passive Investment Disclosure
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting that it beneficially owns 0 shares (0%) of DR Horton Inc common stock as part of an internal realignment dated January 12, 2026. The amendment states certain Vanguard subsidiaries will report holdings separately following SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Amendment documents reporting structure change, not a market trade.
The filing records that The Vanguard Group now reports zero beneficial ownership of DR Horton Inc common stock, attributing holdings to disaggregated subsidiaries after an internal reorganization referenced to SEC Release No. 34-39538.
This is an administrative reporting change; cash‑flow treatment and any subsidiary holdings are not detailed in the excerpt. Subsequent filings by the reporting subsidiaries may show their respective positions.